Non-clear cell renal cell carcinoma
Clinical trials for Non-clear cell renal cell carcinoma explained in plain language.
Never miss a new study
Get alerted when new Non-clear cell renal cell carcinoma trials appear
Sign up with your email to follow new studies for Non-clear cell renal cell carcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy after kidney surgery may delay cancer return in rare kidney cancer
Disease control Not yet recruitingThis phase III trial compares the immunotherapy drug pembrolizumab to active surveillance (no treatment) after kidney cancer surgery in patients with non-clear cell renal cell carcinoma, a less common type of kidney cancer. The goal is to see if pembrolizumab can help the immune …
Matched conditions: NON-CLEAR CELL RENAL CELL CARCINOMA
Phase 3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Blood test may foretell immunotherapy outcomes in rare kidney cancer
Diagnosis Not yet recruitingThis study is testing whether a personalized blood test can predict how well immunotherapy works in people with advanced non-clear cell kidney cancer. The test looks for tiny pieces of tumor DNA in the blood, called circulating tumor DNA (ctDNA), before and during treatment. Rese…
Matched conditions: NON-CLEAR CELL RENAL CELL CARCINOMA
Sponsor: West China Hospital • Aim: Diagnosis
Last updated Aug 22, 2026 00:00 UTC